Michel Perez,
Head of Office
The Development of Innovation Office works with researchers to develop their inventions throughout the acceleration and maturation phases by bringing industrial development skills and helping in attracting specific external funding.
This office is composed of scientists with strong background in industrial research and development.
The Development of Innovation Office works in close collaboration with the Business Development Division, which allows a better understanding of the expectations and needs of our industrial partners, an essential step to propose targeted scientific collaborations and to suggest ambitious development axes.
See More « Accelerator of Innovation »
Biography
Dr. Perez, PhD, joined the Institut Pasteur in 2019 as head of the Development of Innovation Office and head of Therapeutic Innovation development. In this role, he follows the most advanced therapeutic projects of the institute and manages the orientation towards valuable assets for pharmaceutical development. He is also involved in earlier projects that could address breakthrough innovations in fields such as rare diseases, antimicrobial resistance and gene therapy.
Prior to this position, he was a Senior Director in the French pharmaceutical company Pierre Fabre in charge of pre-clinical research programs. Dr. Perez spent more than 25 years in the pharma industry, from research to preclinical development, in fields such as oncology, cardiovascular and central nervous system. During that period, he had the opportunity to work on many projects based on small molecules, antibodies or conjugates. He also had the chance to drive many collaborations not only just with academic institutions such as the CNRS or Universities but also with biotechs and startup.
Before joining Pierre Fabre, Dr. Perez worked as a scientist at the Eisai Research Institute in the Boston area. He is co-author of many articles and patents and has obtained two awards during his career.
Send an Email
